ArticleCancer prevention research (Philadelphia, Pa.)2011

A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.

Syed M Meeran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.